A groundbreaking genetic study has identified four distinct autism subtypes, each characterized by unique symptom patterns, developmental trajectories, and genetic markers.
Published in Nature Genetics, the research by Princeton University and the Simons Foundation challenges the traditional “spectrum” view of autism as a linear range from mild to severe, offering a more nuanced understanding of the condition.
Using a “person-centered” approach, researchers analyzed behavioral and genetic data from over 5,000 children in the SPARK autism cohort, examining 230 traits including social behaviors, repetitive actions, and developmental milestones.
This method diverged from past research that focused on single genes linked to isolated symptoms; instead, the team first defined subtypes and then explored their genetic roots.
The Four Autism Subtypes
Social and behavioral challenges (37% of participants): These individuals reach developmental milestones on par with neurotypical children but experience core autism traits (social difficulties, repetitive behaviors) alongside co-occurring conditions like ADHD, anxiety, or depression.
Mixed ASD with developmental delay (19%): Children in this group show delays in walking or talking but rarely have anxiety, depression, or disruptive behaviors. Their core autism traits present in varied ways, earning the “mixed” label.
Moderate challenges (34%): This group meets developmental milestones normally and displays core autism behaviors with less intensity than other subtypes, with no co-occurring psychiatric conditions.
Broadly affected (10%): The smallest group faces extensive challenges, including severe developmental delays, social/communication issues, intense repetitive behaviors, and co-occurring conditions like mood dysregulation.
Genetic analysis revealed key differences across subtypes. For example, the “social and behavioral challenges” group has gene mutations active later in childhood, aligning with their lack of early delays and later diagnosis.
The “broadly affected” group shows high rates of de novo (new, non-inherited) mutations, which correlate with more severe symptoms. Meanwhile, the “mixed ASD with developmental delay” group is more likely to carry rare inherited genetic variants, highlighting distinct biological pathways.
Researchers emphasize that these four subtypes are a starting point, with potential for more to be identified. The findings offer a data-driven framework to improve diagnosis, personalized support, and research.
For families and clinicians, they clarify why autism manifests so differently across individuals, paving the way for tailored interventions and better anticipation of needs. As Avila Litman, co-lead author, noted: “These subtypes are meaningful in both the clinic and the genome.”
